Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 

Slides:



Advertisements
Similar presentations
Volume 72, Issue 7, Pages (October 2007)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Increased expression of heparanase in overt diabetic nephropathy
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Volume 67, Issue 5, Pages (May 2005)
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 4, Pages (April 2014)
Volume 80, Issue 12, Pages (December 2011)
Volume 70, Issue 4, Pages (August 2006)
Volume 61, Issue 2, Pages (February 2002)
Volume 61, Issue 4, Pages (April 2002)
Volume 72, Issue 4, Pages (August 2007)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 60, Issue 6, Pages (December 2001)
Volume 68, Issue 3, Pages (September 2005)
Volume 69, Issue 10, Pages (May 2006)
Volume 66, Issue 6, Pages (December 2004)
Volume 58, Issue 6, Pages (December 2000)
Volume 58, Issue 4, Pages (October 2000)
Volume 84, Issue 5, Pages (November 2013)
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 77, Issue 11, Pages (June 2010)
Volume 60, Issue 3, Pages (September 2001)
An improved method for primary culture of rat podocytes
Volume 87, Issue 2, Pages (February 2015)
Volume 65, Issue 6, Pages (June 2004)
Volume 73, Issue 8, Pages (April 2008)
Volume 65, Issue 5, Pages (May 2004)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 88, Issue 5, Pages (November 2015)
IL-18 is expressed in the intercalated cell of human kidney
Volume 71, Issue 1, Pages (January 2007)
Proinflammatory effects of iron sucrose in chronic kidney disease
Oliver Vonend, Clare M. Turner  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Volume 72, Issue 8, Pages (October 2007)
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Issue 2, Pages (February 2005)
Volume 58, Issue 1, Pages (July 2000)
Growth hormone promotes glomerular lipid accumulation in bGH mice
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 59, Issue 4, Pages (April 2001)
Volume 74, Issue 5, Pages (September 2008)
Volume 56, Issue 4, Pages (October 1999)
Volume 70, Issue 10, Pages (November 2006)
Volume 67, Issue 4, Pages (April 2005)
Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis  J. Mahmood, F. Khan, S. Okada,
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 65, Issue 2, Pages (February 2004)
Volume 72, Issue 3, Pages (August 2007)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 72, Issue 7, Pages (October 2007)
Volume 68, Issue 2, Pages (August 2005)
Volume 55, Issue 6, Pages (June 1999)
Volume 69, Issue 11, Pages (June 2006)
Volume 69, Issue 11, Pages (June 2006)
Volume 69, Issue 7, Pages (April 2006)
Zinc deficiency further increases the enhanced expression of endothelin-1 in glomeruli of the obstructed kidney  Hiroyuki Yanagisawa, Kazuaki Moridaira,
Endothelin antagonists in renal disease
Volume 70, Issue 2, Pages (July 2006)
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes  Guorong Ma, Terri J. Allen, Mark E. Cooper,
Volume 57, Issue 4, Pages (April 2000)
Volume 65, Issue 6, Pages (June 2004)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 65, Issue 6, Pages (June 2004)
Volume 65, Issue 6, Pages (June 2004)
Presentation transcript:

Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama  Kidney International  Volume 69, Issue 7, Pages 1146-1152 (April 2006) DOI: 10.1038/sj.ki.5000207 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 (a) Proteinuria and histological changes. Twenty four-hour urinary protein excretion in the PAN rats (•) and control rats (▴). Values are expressed as mean±s.d. * indicates P<0.05 for age-matched control. (b) Typical morphological changes of PAN rat FSGS phase (periodic acid-Schiff stain, Original magnification × 160). Segmental sclerosis and hyalinosis lesion were observed (arrow). (c) Electron micrograph of glomerulus at FSGS phase. Foot processes of podocytes were shown variable degrees of fusion and effacement. A portion of the mitochondria profiles in podocytes were enlarged and had a few or incomplete cristae (arrow). (Original magnifications × 5000). Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Glomerular distribution of COX proteins. (a and b) Intraglomerular COX I protein distribution and COX IV (c) at nephrosis phase, (d) COX I, and (e) COX IV at FSGS phase, and (g and h) COX I and (i) COX IV in controls, and nuclei stained by 4,6-diamidino-2-phenylindole in all sections. Intraglomerular COX I protein distribution at nephrosis phase was identical to controls, however, segmental reduction of intraglomerular COX I protein distribution was observed, especially in top of right and bottom of left at FSGS phase. Where as, intraglomerular COX IV protein distribution was identical in all sections. Original magnifications: a, c, d, f, g, and i: × 40; b, e, and h: × 100. Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Proportion of intraglomerular COX I/COX IV proteins. The proportions of COX I/COX IV in glomeruli of PAN, which were quantified as a percentage of age-matched control values. A significant COX I/COX IV reduction was observed at FSGS phase. Values are expressed as mean±s.d. * indicates P<0.05. Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 MtDNA copy-number changes. The proportions of mtDNA copy number to 18SrRNA genome (nuclear DNA) copy number (mtDNA/18SrRNA) quantified as a percentage of age-matched control values in DNA from (a) kidney cortex and isolated (b) glomeruli were shown. DNA from kidney cortex, mtDNA/18SrRNA was constant until 5 days after PA injection, but a significant increase of mtDNA/18SrRNA was observed at nephrosis phase. (a) Furthermore, a significant decrease of mtDNA/18SrRNA was observed at FSGS phase. This change was enhanced in DNA from isolated glomeruli. (b) Sixty-six percent reduction of mtDNA copy number was observed at FSGS phase. Values are expressed as mean±s.d. *P<0.05 compared to each phase of rats. #P<0.05 compared to age-matched controls. Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 MtDNA distribution in glomeruli. Fluorescence in situ Hybridization for mtDNA in glomerulus at (a) FSGS phase (b) and age-matched control. The red signals represented mtDNA molecules, and the blue signals represented the nuclei by DAPI stain. MtDNA signals in glomerulus were decreased at FSGS phase, compared to age-matched control. Original magnifications of a, b: × 100. Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 Expression of mitochondrial DNA (mtDNA) replication molecules. The expressions of mtTFA and NRF-1 and GAPDH mRNA in the glomeruli at day 1 after PA injection, at nephrosis phase, at 52 days and at FSGS phase were examined by reverse transcription-polymerase chain reaction (RT-PCR). The mRNA expression of mtTFA was upregulated at nephrosis phase and was slightly upregulated at 52 days, and downregulated at FSGS phase, compared to each control. The upregulation of NRF-1 mRNA was observed at nephrosis phase and at 52 days, but it was not observed in day 1 and FSGS phase PAN rats and each control rats. Kidney International 2006 69, 1146-1152DOI: (10.1038/sj.ki.5000207) Copyright © 2006 International Society of Nephrology Terms and Conditions